TCR2 Therapeutics Inc. buy quelbe60
Start price
16.10.22
/
50%
€1.68
Target price
16.10.23
-
Performance (%)
-6.83%
End price
30.10.22
€1.56
Summary
This prediction ended on 30.10.22 with a price of €1.56. With a performance of -6.83%, the BUY prediction for TCR2 Therapeutics Inc. by quelbe60 closed slightly in the red. quelbe60 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| TCR2 Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % | 44,61 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % | 70,74 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % | 48,21 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % | 54,25 % |
According to quelbe60 what are the pros and cons of TCR2 Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by quelbe60 for this prediction
In the thread Tcr2 Therapeutics Inc. diskutieren
Buy TCR2 Therapeutics Inc.